Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Claglid MV 0.3mg/500mg/30mg Tablet

Prescription Icon
Prescription Required

Marketer

Proqol Healthcare

Salt Composition

Voglibose (0.3mg) + Metformin (500mg) + Gliclazide (30mg)

Overview Claglid MV 0.3mg/500mg/30mg Tablet

Diabetease Trio 0.3mg/500mg/30mg tablets are antidiabetic medications combining three drugs to manage type 2 diabetes in adults. This formulation helps regulate blood glucose. Consume Diabetease Trio with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; learn its symptoms (sweating, dizziness, headache, trembling) and appropriate countermeasures (fast-acting glucose sources). Alcohol increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, vomiting, diarrhea, abdominal pain, headache, swelling, blurred vision, and bone fractures; weight gain may occur. Diabetease Trio is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose checks, along with blood counts and liver function monitoring via blood tests, are recommended.

Uses of Claglid MV 0.3mg/500mg/30mg Tablet

Managing Type 2 Diabetes

Major Benefits of Claglid MV 0.3mg/500mg/30mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Claglid MV 0.3mg/500mg/30mg Tablet whole; avoid chewing, crushing, or fracturing. Consume with food.

Common Side effects of Claglid MV 0.3mg/500mg/30mg Tablet:

  • Nausea
  • Hypoglycemia (low blood glucose level)
  • Abdominal pain
  • Constipation

How to use Claglid MV 0.3mg/500mg/30mg Tablet:

Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the Claglid MV 0.3mg/500mg/30mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Claglid MV 0.3mg/500mg/30mg Tablet works:

One tablet of Claglid MV contains 0.3mg, 500mg, and 30mg of three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Claglid MV 0.3mg/500mg/30mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Claglid MV 0.3mg/500mg/30mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCAUTION

The use of Claglid MV 0.3mg/500mg/30mg tablets requires careful consideration while breastfeeding. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Claglid MV 0.3mg/500mg/30mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Claglid MV 0.3mg/500mg/30mg tablets. Medical supervision and regular kidney function assessments are recommended during treatment.

LiverLiverCAUTION

Patients with liver disease should use Claglid MV 0.3mg/500mg/30mg tablets cautiously. Dosage modification may be necessary. Consult a physician for guidance. For those with mild to moderate liver impairment, initiation should be at a low dosage; its use is contraindicated in patients with severe liver disease.

What if you forget to take Claglid MV 0.3mg/500mg/30mg Tablet :

NA

Facts to Know About Claglid MV 0.3mg/500mg/30mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Claglid MV 0.3mg/500mg/30...
69
MRP 80
13% off